Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice

References

• Palomero T, Ferrando A. Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. Clin Cancer Res 2008; 14:5314-7; PMID:18765521; http://dx.doi.org/10.1158/1078-0432.CCR-07-4864
   PubMed Web of Science ®Google Scholar
• Timakhov RA, Tan Y, Rao M, Liu Z, Altomare DA, Pei J, Wiest DL, Favorova OO, Knepper JE, Testa JR. Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic mice. Genes Chromosomes Cancer 2009; 48:786-94; PMID:19530243; http://dx.doi.org/10.1002/gcc.20683
   PubMed Web of Science ®Google Scholar
• Tan Y, Timakhov RA, Rao M, Altomare DA, Xu J, Liu Z, Gao Q, Jhanwar SC, Di Cristofano A, Wiest DL, et al. A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice. Cancer Res 2008; 68:1296-302; PMID:18316591; http://dx.doi.org/10.1158/0008-5472.CAN-07-3218
   PubMed Web of Science ®Google Scholar
• Douglas NC, Jacobs H, Bothwell AL, Hayday AC. Defining the specific physiological requirements for c-Myc in T cell development. Nat Immunol 2001; 2:307-15; PMID:11276201; http://dx.doi.org/10.1038/86308
   PubMed Web of Science ®Google Scholar
• Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP, Lin S, Prochownik E, Trede NS, Zon LI, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003; 299:887-90; PMID:12574629;http://dx.doi.org/10.1126/science.1080280
   PubMed Web of Science ®Google Scholar
• Rudolph B, Hueber AO, Evan GI. Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro. Oncogene 2000; 19:1891-900; PMID:10773879; http://dx.doi.org/10.1038/sj.onc.1203508
   PubMed Web of Science ®Google Scholar
• Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet 2013; 381:1943-55; PMID:23523389; http://dx.doi.org/10.1016/S0140-6736(12)62187-4
   PubMed Web of Science ®Google Scholar
• Chiarini F, Fala F, Tazzari PL, Ricci F, Astolfi A, Pession A, Pagliaro P, McCubrey JA, Martelli AM. Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia. Cancer Res 2009; 69:3520-8; PMID:19351820; http://dx.doi.org/10.1158/0008-5472.CAN-08-4884
   PubMed Web of Science ®Google Scholar
• O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C, Hardwick J, Welcker M, Meijerink JP, Pieters R, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204:1813-24; PMID:17646409; http://dx.doi.org/10.1084/jem.20070876
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, et al. Selective inhibition of BET bromodomains. Nature 2010; 468:1067-73; PMID:20871596; http://dx.doi.org/10.1038/nature09504
   PubMed Web of Science ®Google Scholar
• Roderick JE, Tesell J, Shultz LD, Brehm MA, Greiner DL, Harris MH, Silverman LB, Sallan SE, Gutierrez A, Look AT, et al. c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells. Blood 2014; 123:1040-50; PMID:24394663; http://dx.doi.org/10.1182/blood-2013-08-522698
   PubMed Web of Science ®Google Scholar
• Huang MJ, Cheng YC, Liu CR, Lin S, Liu HE. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp Hematol 2006; 34:1480-9; PMID:17046567; http://dx.doi.org/10.1016/j.exphem.2006.06.019
   PubMed Web of Science ®Google Scholar
• Guo J, Parise RA, Joseph E, Egorin MJ, Lazo JS, Prochownik EV, Eiseman JL. Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice. Cancer Chemother Pharmacol 2009; 63:615-25; PMID:18509642; http://dx.doi.org/10.1007/s00280-008-0774-y
   PubMed Web of Science ®Google Scholar
• Xu J, Testa JR. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC. J Biol Chem 2009; 284:20593-601; PMID:19497851; http://dx.doi.org/10.1074/jbc.M109.021477
   PubMed Web of Science ®Google Scholar
• Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, Del Bianco C, Rodriguez CG, Sai H, Tobias J, et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 2006; 20:2096-109; PMID:16847353; http://dx.doi.org/10.1101/gad.1450406
   PubMed Web of Science ®Google Scholar
• Kindler T, Cornejo MG, Scholl C, Liu J, Leeman DS, Haydu JE, Fröhling S, Lee BH, Gilliland DG. K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors. Blood 2008; 112:3373-82; PMID:18663146; http://dx.doi.org/10.1182/blood-2008-03-147587
   PubMed Web of Science ®Google Scholar
• Sanda T, Li X, Gutierrez A, Ahn Y, Neuberg DS, O'Neil J, Strack PR, Winter CG, Winter SS, Larson RS, et al. Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood 2010; 115:1735-45; PMID:20007543; http://dx.doi.org/10.1182/blood-2009-07-235143
   PubMed Web of Science ®Google Scholar
• Tan Y, Cheung M, Pei J, Menges CW, Godwin AK, Testa JR. Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling. Cancer Res 2010; 70:9197-206; PMID:21045156; http://dx.doi.org/10.1158/0008-5472.CAN-10-1568
   PubMed Web of Science ®Google Scholar
• Huang K, Fingar DC. Growing knowledge of the mTOR signaling network. Semin Cell Dev Biol 2014; 36:79-90; PMID:25242279; http://dx.doi.org/10.1016/j.semcdb.2014.09.011
   PubMed Web of Science ®Google Scholar
• Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994; 369:756-8; PMID:8008069; http://dx.doi.org/10.1038/369756a0
   PubMed Web of Science ®Google Scholar
• Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992; 69:1227-36; PMID:1377606; http://dx.doi.org/10.1016/0092-8674(92)90643-Q
   PubMed Web of Science ®Google Scholar
• Kawamata S, Sakaida H, Hori T, Maeda M, Uchiyama T. The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines. Blood 1998; 91:561-9; PMID:9427710
   PubMed Web of Science ®Google Scholar
• Serra V, Markman B, Scaltriti M, Eichhorn PJ, Valero V, Guzman M, Botero ML, Llonch E, Atzori F, Di Cosimo S, et al. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations. Cancer Res 2008; 68:8022-30; PMID:18829560; http://dx.doi.org/10.1158/0008-5472.CAN-08-1385
   PubMed Web of Science ®Google Scholar
• Blackwood EM, Eisenman RN. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991; 251:1211-7; PMID:2006410; http://dx.doi.org/10.1126/science.2006410
   PubMed Web of Science ®Google Scholar
• Prendergast GC, Ziff EB. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 1991; 251:186-9; PMID:1987636; http://dx.doi.org/10.1126/science.1987636
   PubMed Web of Science ®Google Scholar
• Xiong J, Du Q, Liang Z. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 2010; 29:4980-8; PMID:20562918; http://dx.doi.org/10.1038/onc.2010.241
   PubMed Web of Science ®Google Scholar